Works matching DE "INSULIN secretagogues"
Results: 85
Evaluating the Impact of Intensifying Treatment from Human to Analogue Insulin on Glycaemic Control and Insulin Expenditure in Patients with Type 2 Diabetes: A Retrospective Cohort Study.
- Published in:
- Malaysian Journal of Medical Sciences, 2024, v. 31, n. 2, p. 159, doi. 10.21315/mjms2024.31.2.14
- By:
- Publication type:
- Article
Hypolipidaemic and Insulin Secretagogue Activities of (R)-(-)-Carvone.
- Published in:
- Malaysian Journal of Medical Sciences, 2020, v. 27, n. 6, p. 39, doi. 10.21315/mjms2020.27.6.5
- By:
- Publication type:
- Article
Diabetes therapy-focus on Asia: second-line therapy debate: insulin/secretagogues.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
UKPDS at 44 years.
- Published in:
- Diabetes & Primary Care, 2024, v. 26, n. 3, p. 103
- By:
- Publication type:
- Article
Fine‐tuned photochromic sulfonylureas for optical control of beta cell Ca<sup>2+</sup> fluxes.
- Published in:
- Diabetic Medicine, 2023, v. 40, n. 12, p. 1, doi. 10.1111/dme.15220
- By:
- Publication type:
- Article
Overtreatment of older people with type 2 diabetes—a high impact frequent occurrence in need of a new definition.
- Published in:
- Diabetic Medicine, 2023, v. 40, n. 2, p. 1, doi. 10.1111/dme.14994
- By:
- Publication type:
- Article
The science behind hypoglycemia: Why blood sugar levels drop and how to fix it.
- Published in:
- African Journal of Diabetes Medicine, 2024, v. 32, n. 5, p. 1, doi. 10.54931/AJDM-32.5.4
- By:
- Publication type:
- Article
Diabetics treated with insulin, sulfonylureas or other insulin secretagogues are at high risk of hypoglycemia.
- Published in:
- African Journal of Diabetes Medicine, 2023, v. 31, n. 2, p. 1
- By:
- Publication type:
- Article
Turmeric improves glycemic control and exhibits insulin secretagogue activity in Alloxan induced diabetic rat model.
- Published in:
- Professional Medical Journal, 2022, v. 29, n. 4, p. 495, doi. 10.29309/TPMJ/2022.29.04.6558
- By:
- Publication type:
- Article
Comment on: Willingness to take less medication for type 2 diabetes among older patients.
- Published in:
- Journal of the American Geriatrics Society, 2024, v. 72, n. 11, p. 3607, doi. 10.1111/jgs.19175
- By:
- Publication type:
- Article
Decline in use of high‐risk agents for tight glucose control among older adults with diabetes in New York City: 2017–2022.
- Published in:
- Journal of the American Geriatrics Society, 2024, v. 72, n. 9, p. 2721, doi. 10.1111/jgs.19060
- By:
- Publication type:
- Article
Crossing the deintensification chasm for older adults with diabetes.
- Published in:
- Journal of the American Geriatrics Society, 2024, v. 72, n. 7, p. 1952, doi. 10.1111/jgs.18944
- By:
- Publication type:
- Article
Reply to: Comment on: Association of sulfonylureas with the risk of dementia: A population‐based cohort study.
- Published in:
- Journal of the American Geriatrics Society, 2024, v. 72, n. 4, p. 1290, doi. 10.1111/jgs.18769
- By:
- Publication type:
- Article
Comment on: Association of sulfonylureas with the risk of dementia: A population‐based cohort study.
- Published in:
- Journal of the American Geriatrics Society, 2024, v. 72, n. 4, p. 1288, doi. 10.1111/jgs.18767
- By:
- Publication type:
- Article
Disease latency and new‐user versus prevalent‐user cohort designs: Implications for pharmacoepidemiology in dementia.
- Published in:
- Journal of the American Geriatrics Society, 2024, v. 72, n. 3, p. 953, doi. 10.1111/jgs.18714
- By:
- Publication type:
- Article
"The price is right" for diabetes management of older adults – Evidence for the closest glycemic target without going over.
- Published in:
- Journal of the American Geriatrics Society, 2023, v. 71, n. 12, p. 3680, doi. 10.1111/jgs.18658
- By:
- Publication type:
- Article
Glycemic control and diabetes complications across health status categories in older adults treated with insulin or insulin secretagogues: The Diabetes & Aging Study.
- Published in:
- Journal of the American Geriatrics Society, 2023, v. 71, n. 12, p. 3692, doi. 10.1111/jgs.18565
- By:
- Publication type:
- Article
Association of sulfonylureas with the risk of dementia: A population‐based cohort study.
- Published in:
- Journal of the American Geriatrics Society, 2023, v. 71, n. 10, p. 3059, doi. 10.1111/jgs.18397
- By:
- Publication type:
- Article
Adoption of sodium‐glucose cotransporter‐2 inhibitors among prescribers caring for nursing home residents.
- Published in:
- Journal of the American Geriatrics Society, 2023, v. 71, n. 8, p. 2585, doi. 10.1111/jgs.18360
- By:
- Publication type:
- Article
Comparative safety of sulfonylureas among U.S. nursing home residents.
- Published in:
- Journal of the American Geriatrics Society, 2023, v. 71, n. 4, p. 1047, doi. 10.1111/jgs.18160
- By:
- Publication type:
- Article
Failure to metformin and insulin secretagogue monotherapy: an observational cohort study.
- Published in:
- Acta Diabetologica, 2010, v. 47, p. 7, doi. 10.1007/s00592-009-0104-9
- By:
- Publication type:
- Article
Differential lipid profile and hormonal response in type 2 diabetes by exogenous insulin aspart versus the insulin secretagogue repaglinide, at the same glycemic control.
- Published in:
- Acta Diabetologica, 2009, v. 46, n. 1, p. 35, doi. 10.1007/s00592-008-0055-6
- By:
- Publication type:
- Article
Annual dialysis data report 2018, JSDT Renal Data Registry: dialysis fluid quality, hemodialysis and hemodiafiltration, peritoneal dialysis, and diabetes.
- Published in:
- Renal Replacement Therapy, 2020, v. 6, n. 1, p. N.PAG, doi. 10.1186/s41100-020-00290-z
- By:
- Publication type:
- Article
Association of Glucose-Lowering Drugs With Outcomes in Patients With Diabetes Before Hospitalization for COVID-19: A Systematic Review and Network Meta-analysis.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 12, p. e2244652, doi. 10.1001/jamanetworkopen.2022.44652
- By:
- Publication type:
- Article
Pancreatic β cell models for screening insulin secretagogues and cytotoxicity.
- Published in:
- Journal of Applied Toxicology, 2025, v. 45, n. 1, p. 89, doi. 10.1002/jat.4658
- By:
- Publication type:
- Article
Causes of In-Hospital Death and Pharmaceutical Associations with Age of Death during a 10-Year Period (2011–2020) in Individuals with and without Diabetes at a Japanese Community General Hospital.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 5, p. 1283, doi. 10.3390/jcm13051283
- By:
- Publication type:
- Article
Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 5, p. 985, doi. 10.3390/jcm10050985
- By:
- Publication type:
- Article
Systematic Review of Cardiovascular Outcomes with Sulfonylureas, GLP-1 RA, and DPP-4 Inhibitors in Type 2 Diabetes Mellitus.
- Published in:
- Journal of Diabetology: Official Journal of Diabetes in Asia Study Group, 2024, v. 15, n. 3, p. 266, doi. 10.4103/jod.jod_80_24
- By:
- Publication type:
- Article
Notoginsenoside R1, a metabolite from Panax notoginseng (Burkill) F.H.Chen, stimulates insulin secretion through activation of phosphatidylinositol 3-kinase (PI3K)/Akt pathway.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1478917
- By:
- Publication type:
- Article
Notoginsenoside R1, a metabolite from Panax notoginseng (Burkill) F.H.Chen, stimulates insulin secretion through activation of phosphatidylinositol 3-kinase (PI3K)/Akt pathway.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1478917
- By:
- Publication type:
- Article
Notoginsenoside R1, a metabolite from Panax notoginseng (Burkill) F.H.Chen, stimulates insulin secretion through activation of phosphatidylinositol 3-kinase (PI3K)/Akt pathway.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1478917
- By:
- Publication type:
- Article
Safety and Effectiveness of Sodium-Glucose Co-transporter 2 Inhibitors on Glycemic Control in Patients with Type 2 Diabetes Mellitus Fasting during Ramadan: A Review.
- Published in:
- Clinical Medicine Insights: Endocrinology & Diabetes, 2024, p. 1, doi. 10.1177/11795514241238058
- By:
- Publication type:
- Article
PREBIOTICS PROGRESS SHIFTS IN THE INTESTINAL MICROBIOME THAT BENEFITS PATIENTS WITH TYPE 2 DIABETES MELLITUS.
- Published in:
- Australasian College of Nutritional & Environmental Medicine Journal, 2024, v. 43, n. 2, p. 30
- By:
- Publication type:
- Article
Oral insulin secretagogues, insulin, and cancer risk in type 2 diabetes mellitus.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Type 2 diabetes and insulin secretagogues.
- Published in:
- 2012
- By:
- Publication type:
- journal article
IN VITRO AND IN VIVO EVALUATION OF THE ANTI-DIABETIC ACTIVITY AND INHIBITORY ACTIVITY OF ANNONA SQUAMOSA LEAVES.
- Published in:
- Biochemical & Cellular Archives, 2024, v. 24, n. 2, p. 3063, doi. 10.51470/bca.2024.24.2.3063
- By:
- Publication type:
- Article
Diabetes medications and cancer risk associations: a systematic review and meta-analysis of evidence over the past 10 years.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-38431-z
- By:
- Publication type:
- Article
Venom Peptides, Polyphenols and Alkaloids: Are They the Next Antidiabetics That Will Preserve β-Cell Mass and Function in Type 2 Diabetes?
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 6, p. 940, doi. 10.3390/cells12060940
- By:
- Publication type:
- Article
Association between residual islet beta‐cell function and achieving the target of time in range in inpatients with type 2 diabetes undergoing antidiabetic treatment: An observation study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1714, doi. 10.1111/dom.15026
- By:
- Publication type:
- Article
β-Cell signalling and insulin secretagogues: A path for improved diabetes therapy.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, p. 22, doi. 10.1111/dom.12995
- By:
- Publication type:
- Article
Variations in tissue selectivity amongst insulin secretagogues: a systematic review.
- Published in:
- Diabetes, Obesity & Metabolism, 2012, v. 14, n. 2, p. 130, doi. 10.1111/j.1463-1326.2011.01496.x
- By:
- Publication type:
- Article
Continuation versus discontinuation of insulin secretagogues when initiating insulin in type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2010, v. 12, n. 10, p. 923, doi. 10.1111/j.1463-1326.2010.01258.x
- By:
- Publication type:
- Article
Desensitization of Insulin Secretion by DepolarizingInsulin Secretagogues.
- Published in:
- Diabetes, 2004, v. 53, p. S140, doi. 10.2337/diabetes.53.suppl_3.S140
- By:
- Publication type:
- Article
Beta-cell calcium-independent group VIA phospholipase A(2) (iPLA(2)beta): tracking iPLA(2)beta movements in response to stimulation with insulin secretagogues in INS-1 cells.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Journal club: Back to basics -- an update on lifestyle factors, preventing gestational diabetes and sulfonylureas.
- Published in:
- Journal of Diabetes Nursing, 2023, v. 27, n. 4, p. 1
- By:
- Publication type:
- Article
Cost-effective Analysis of Prescribed Oral Hypoglycemic Agents amongst Pre-obese and Obese Diabetic Patients in a Tertiary Care Hospital in Odisha.
- Published in:
- Global Journal of Medical Pharmaceutical & Biomedical Update, 2023, v. 18, p. 1, doi. 10.25259/GJMPBU_23_2023
- By:
- Publication type:
- Article
Cardiovascular disease management in Australian adults with type 2 diabetes: insights from the CAPTURE study.
- Published in:
- Internal Medicine Journal, 2023, v. 53, n. 10, p. 1796, doi. 10.1111/imj.15929
- By:
- Publication type:
- Article
Retatrutide.
- Published in:
- Clinical Diabetes, 2024, v. 42, n. 4, p. 579, doi. 10.2337/cd24-0062
- By:
- Publication type:
- Article
Deceived by Elevated A1C: Cases of Misdiagnosed Diabetes.
- Published in:
- Clinical Diabetes, 2024, v. 42, n. 1, p. 150, doi. 10.2337/cd23-0043
- By:
- Publication type:
- Article
Clinical Considerations and Practical Advice for People Living With Type 2 Diabetes Who Undertake Regular Exercise or Aim to Exercise Competitively.
- Published in:
- Diabetes Spectrum, 2023, v. 36, n. 2, p. 114, doi. 10.2337/dsi22-0015
- By:
- Publication type:
- Article